Exhibition · Suntec City, Singapore
Generics and Biosimilars Asia
Biotechnology · Medicine
Key numbers
- Editions on record
- 1first in 2011
About Generics and Biosimilars Asia
According to companiesandmarkets.com, the global generics market is forecast to be valued at $183.2 billion by 2014 and Asia Pacific will account for 36.2% of the global generics market. With an impressive CAGR of 12.9% through 2009-2012 and annual returns of US $200 billion from patents expiring in the next five years, the generics industry is looking at the next wave of evolution as big pharmaceutical companies start eyeing a bigger share of the generic drugs market.
With strong demand for affordable healthcare throughout Asia governments are favoring the production and prescription of generics and biosimilars. The Generics & Biosimilars Asia 2011 conference is set to address many of the pressing issues faced by both innovator and generic drug companies. Attendees will be able to network, discuss and learn from peers facing similar challenges in market access, pricing and the evolving pharmaceutical industry.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2011 | 3–4 Mar 2011 | Amara Singapore Suntec City, Singapore | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Generics and Biosimilars Asia?
The next dates haven't been confirmed. The last edition we have on record was 3–4 Mar 2011.
Where is it held?
The last edition we have was at Amara Singapore, Suntec City, Singapore.